J Ampj Update 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U.S. authorities recommended pause after clot cases
Belgium says won’t stop J&J shot’s rollout (adds EU spokesman)
BRUSSELS, April 13 (Reuters) - The European Commission is seeking clarification from Johnson & Johnson about the company’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU, an EU official told Reuters on Tuesday.
The U.S. company said it would delay rolling out the vaccine in Europe after U.S. federal health agencies recommended pausing the use of the vaccine following cases of rare blood clots in six women under 50 after they were given it.
Despite the U.S. decision, Belgium said it would not stop its rollout at this stage, while the Dutch drug regulator said benefits of the J&J vaccine outweighed possible risks, and Spain said it was not aware of any delay. ....

United States , Bruxelles Capitale , Alexandra Hudson , Francesco Guarascio , Stella Kyriakides , John Stonestreet , Gabriela Baczynska , Thomson Reuters Trust Principles , Eu Health , European Commission , A Commission , European Union , European Medicines Agency , Commissioner Stella Kyriakides , Thomson Reuters Trust , Coronavirus Eu , J Ampj Update 3 , Corporate Events , Eu Institutions , Company News , Corona Virus , United Kingdom , General News , General Health , Health Medicine , Healthcare Trbc Level 1 ,